LncRNA UCA1 affects osteoblast proliferation and differentiation by regulating BMP-2 expression

Area of Science:

• Molecular Biology
• Biochemistry
• Cell Biology

Background:

• Osteoporosis (OST) is a skeletal disorder characterized by decreased bone mass and increased fracture risk.
• Long non-coding RNAs (lncRNAs) are emerging as key regulators in various biological processes, including bone metabolism.
• Urothelial carcinoma associated 1 (UCA1) is a lncRNA whose role in osteoporosis remains largely unexplored.

Purpose of the Study:

• To investigate the expression of lncRNA UCA1 in the plasma of osteoporosis patients.
• To elucidate the functional role of UCA1 in osteoblast proliferation and differentiation.
• To explore the underlying molecular mechanism involving the BMP-2/(Smad1/5/8) signaling pathway.

Main Methods:

• Plasma samples from 52 OST patients and 30 healthy controls were analyzed for UCA1 expression using RT-PCR.
• Osteoblast MC3T3-E1 cell lines with UCA1 knockout were generated using siRNA.
• Cell proliferation was assessed by CCK-8 assay and EdU staining.
• Osteoblast differentiation was evaluated by gene and protein expression analysis (Runx2, Collagen1α1, OPG, OPN, OSX, alkaline phosphatase) and alizarin red staining.
• BMP-2/(Smad1/5/8) signaling pathway activation was analyzed via Western blotting.

Main Results:

• Plasma UCA1 levels were significantly higher in OST patients compared to healthy controls (p<0.05).
• UCA1 knockdown in osteoblasts promoted cell proliferation and differentiation.
• Inhibition of UCA1 led to increased expression of osteoblast differentiation markers and activation of the BMP-2/(Smad1/5/8) signaling pathway.

Conclusions:

• lncRNA UCA1 is upregulated in osteoporosis and negatively regulates osteoblast function.
• Inhibiting UCA1 promotes osteoblast proliferation and differentiation, potentially by activating the BMP-2/(Smad1/5/8) signaling pathway.
• UCA1 represents a promising novel therapeutic target for the treatment of osteoporosis.